Detection of CYP2C19 alleles*1,*2 and*3 by multiplex polymerase chain reaction

被引:0
作者
Griese, EU [1 ]
Läpple, F [1 ]
Eichelbaum, M [1 ]
机构
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany
来源
PHARMACOGENETICS | 1999年 / 9卷 / 03期
关键词
genotyping; CYP2C19; multiplex PCR;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:389 / 391
页数:3
相关论文
共 14 条
[1]   PRONOUNCED DIFFERENCES BETWEEN NATIVE CHINESE AND SWEDISH POPULATIONS IN THE POLYMORPHIC HYDROXYLATIONS OF DEBRISOQUIN AND S-MEPHENYTOIN [J].
BERTILSSON, L ;
LOU, YQ ;
DU, YL ;
LIU, Y ;
KUANG, TY ;
LIAO, XM ;
WANG, KY ;
REVIRIEGO, J ;
ISELIUS, L ;
SJOQVIST, F .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 51 (04) :388-397
[2]   Use of omeprazole as a probe drug for CYP2C19 phenotype in Swedish Caucasians: Comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype [J].
Chang, M ;
Dahl, ML ;
Tybring, G ;
Gotharson, E ;
Bertilsson, L .
PHARMACOGENETICS, 1995, 5 (06) :358-363
[3]  
DEMORAIS SMF, 1994, MOL PHARMACOL, V46, P594
[4]  
DEMORAIS SMF, 1994, J BIOL CHEM, V269, P15419
[5]   Genetic polymorphism of S-mephenytoin 4'-hydroxylation in African-Americans [J].
Edeki, TI ;
Goldstein, JA ;
deMorais, SMF ;
Hajiloo, L ;
Butler, M ;
Chapdelaine, P ;
Wilkinson, GR .
PHARMACOGENETICS, 1996, 6 (04) :357-360
[6]  
Ferguson RJ, 1998, J PHARMACOL EXP THER, V284, P356
[7]   BIOCHEMISTRY AND MOLECULAR-BIOLOGY OF THE HUMAN CYP2C SUBFAMILY [J].
GOLDSTEIN, JA ;
DEMORAIS, SMF .
PHARMACOGENETICS, 1994, 4 (06) :285-299
[8]   Genetic tests which identify the principal defects in CYP2C19 responsible for the polymorphism in mephenytoin metabolism [J].
Goldstein, JA ;
Blaisdell, J .
CYTOCHROME P450, PT B, 1996, 272 :210-218
[9]  
Ibeanu GC, 1998, J PHARMACOL EXP THER, V286, P1490
[10]   An additional defective allele, CYP2C19*5, contributes to the S-mephenytoin poor metabolizer phenotype in Caucasians [J].
Ibeanu, GC ;
Blaisdell, J ;
Ghanayem, BI ;
Beyeler, C ;
Benhamou, S ;
Bouchardy, C ;
Wilkinson, GR ;
Dayer, P ;
Daly, AK ;
Goldstein, JA .
PHARMACOGENETICS, 1998, 8 (02) :129-135